Article Information
History
- July 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mohamed O. Mohamed, MRCP(UK)1,2,
- Tim Kinnaird, MD1,3,
- Nick Curzen, PhD FRCP4,
- Peter Ludman, MD5,
- Jianhua Wu, PhD6,
- Muhammad Rashid, PhD1,2,
- Ahmad Shoaib, MD1,2,
- Mark de Belder, MD FRCP7,
- John Deanfield, FRCP8,
- Chris P Gale, PhD FRCP6,9,10 and
- Mamas A. Mamas, DPhil1,2,*
- 1Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, United Kingdom
- 2Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom
- 3Department of cardiology, University hospital of Wales, Cardiff, Wales, UK
- 4Wessex Cardiothoracic Unit, Southampton University Hospital Southampton & Faculty of Medicine University of Southampton, UK
- 5Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
- 6Leeds Institute for Data analytics, University of Leeds, Leeds, UK
- 7National Institute for Cardiovascular Outcomes Research, Barts Health NHS Trust, London, UK
- 8Institute of Cardiovascular Sciences, University College London, UK
- 9Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK
- 10Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
- ↵*Correspondence to: Mamas A. Mamas, Professor of Cardiology, Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, UK, mamasmamas1{at}yahoo.co.uk
Posted July 27, 2020.
In-hospital and 30-day mortality after percutaneous coronary intervention in England before and after the COVID-19 era
